Literature DB >> 23002344

Clinicopathologic significance of expression of nuclear factor-κB RelA and its target gene products in gastric cancer patients.

Hyuk-Chan Kwon1, Sung-Hyun Kim, Sung Yong Oh, Suee Lee, Ji Hyun Lee, Jin Seok Jang, Min Chan Kim, Ki Han Kim, Su-Jin Kim, Seong-Geun Kim, Hyo-Jin Kim.   

Abstract

AIM: To assess the prognostic significance of nuclear factor-κB (NF-κB) and its target genes in gastric cancer.
METHODS: The tumor tissues of 115 patients with gastric cancer were immunohistochemically evaluated using monoclonal antibodies against NF-κB RelA. Preoperative serum levels of vascular endothelial growth factor (VEGF), interleukin-6 (IL-6) were assessed via enzyme-linked immuno-sorbent assay. C-reactive protein (CRP) and serum amyloid A (SAA) were measured via immunotrubidimetry.
RESULTS: Positive rate of NF-κB RelA was 42.6%. NF-κB RelA expression in tumor tissues was also related to serum levels of IL-6 (P = 0.044) and CRP (P = 0.010). IL-6, SAA, CRP were related to depth of invasion, VEGF and SAA were correlated with lymph node metastasis. IL-6, VEGF, SAA and CRP were related to the stage. Univariate analysis demonstrated that immunostaining of NF-κB RelA, levels of IL-6, VEGF, SAA were significantly related with both disease free survival and overall survival (OS). Multivariate analysis verified that NF-κB RelA [hazard ratio (HR): 3.40, P = 0.024] and SAA (HR: 3.39, P = 0.045) were independently associated with OS.
CONCLUSION: Increased expression of NF-κB RelA and high levels of serum SAA were associated with poor OS in gastric cancer patients.

Entities:  

Keywords:  C-reactive protein; Carcinoma; Interleukin-6; Nuclear factor-κB; Serum amyloid A; Stomach; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2012        PMID: 23002344      PMCID: PMC3442213          DOI: 10.3748/wjg.v18.i34.4744

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Prognostic significance of serum vascular endothelial growth factor per platelet count in unresectable advanced gastric cancer patients.

Authors:  Hee Yeon Seo; Joong Min Park; Kyong Hwa Park; Seok Jin Kim; Sang Cheul Oh; Byung Soo Kim; Yeul Hong Kim; Jun Suk Kim
Journal:  Jpn J Clin Oncol       Date:  2010-07-20       Impact factor: 3.019

2.  Nuclear factor-kappaB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue.

Authors:  N Sasaki; T Morisaki; K Hashizume; T Yao; M Tsuneyoshi; H Noshiro; K Nakamura; T Yamanaka; A Uchiyama; M Tanaka; M Katano
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

3.  Evaluation of serum amyloid A as a biomarker for gastric cancer.

Authors:  De-Chuan Chan; Cheng-Jueng Chen; Heng-Cheng Chu; Wei-Kuo Chang; Jyh-Cherng Yu; Yu-Ju Chen; Li-Li Wen; Su-Ching Huang; Chih-Hung Ku; Yao-Chi Liu; Jenn-Han Chen
Journal:  Ann Surg Oncol       Date:  2006-10-25       Impact factor: 5.344

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 5.  Transcription factor NF-kappaB: a sensor for smoke and stress signals.

Authors:  Kwang Seok Ahn; Bharat B Aggarwal
Journal:  Ann N Y Acad Sci       Date:  2005-11       Impact factor: 5.691

Review 6.  Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen.

Authors:  D R Schultz; P I Arnold
Journal:  Semin Arthritis Rheum       Date:  1990-12       Impact factor: 5.532

Review 7.  Serum amyloid A: an acute-phase protein involved in tumour pathogenesis.

Authors:  E Malle; S Sodin-Semrl; A Kovacevic
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

8.  Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma.

Authors:  Shu Zheng; Ming-Yong Han; Zuo-Xiang Xiao; Jia-Ping Peng; Qi Dong
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

Review 9.  Vascular endothelial growth factor: basic science and clinical progress.

Authors:  Napoleone Ferrara
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

10.  Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer.

Authors:  Do-Kyong Kim; Sung Yong Oh; Hyuk-Chan Kwon; Suee Lee; Kyung A Kwon; Byung Geun Kim; Seong-Geun Kim; Sung-Hyun Kim; Jin Seok Jang; Min Chan Kim; Kyeong Hee Kim; Jin-Yeong Han; Hyo-Jin Kim
Journal:  BMC Cancer       Date:  2009-05-20       Impact factor: 4.430

View more
  17 in total

Review 1.  Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies.

Authors:  Sahil Gambhir; Dinesh Vyas; Michael Hollis; Apporva Aekka; Arpita Vyas
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

Review 2.  Signaling pathways and therapeutic interventions in gastric cancer.

Authors:  Zi-Ning Lei; Qiu-Xu Teng; Qin Tian; Wei Chen; Yuhao Xie; Kaiming Wu; Qianlin Zeng; Leli Zeng; Yihang Pan; Zhe-Sheng Chen; Yulong He
Journal:  Signal Transduct Target Ther       Date:  2022-10-08

Review 3.  Role of the tumor microenvironment in the pathogenesis of gastric carcinoma.

Authors:  Hye Won Chung; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

4.  S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer.

Authors:  Jianli Zhang; Kejun Zhang; Xiuli Jiang; Jian Zhang
Journal:  Dig Dis Sci       Date:  2014-04-05       Impact factor: 3.199

5.  The NFKB1 polymorphism (rs4648068) is associated with the cell proliferation and motility in gastric cancer.

Authors:  Ying Chen; Renquan Lu; Hui Zheng; Ran Xiao; Jingjing Feng; Hongling Wang; Xiang Gao; Lin Guo
Journal:  BMC Gastroenterol       Date:  2015-02-14       Impact factor: 3.067

6.  The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression.

Authors:  Chang-Ni Lin; Chih-Jung Wang; Ying-Jui Chao; Ming-Derg Lai; Yan-Shen Shan
Journal:  BMC Cancer       Date:  2015-03-15       Impact factor: 4.430

7.  Identification of differentially expressed serum proteins in gastric adenocarcinoma.

Authors:  Yashwanth Subbannayya; Sartaj Ahmad Mir; Santosh Renuse; Srikanth S Manda; Sneha M Pinto; Vinuth N Puttamallesh; Hitendra Singh Solanki; H C Manju; Nazia Syed; Rakesh Sharma; Rita Christopher; M Vijayakumar; K V Veerendra Kumar; T S Keshava Prasad; Girija Ramaswamy; Rekha V Kumar; Aditi Chatterjee; Akhilesh Pandey; Harsha Gowda
Journal:  J Proteomics       Date:  2015-05-05       Impact factor: 4.044

8.  Epigenetic Upregulation of Metallothionein 2A by Diallyl Trisulfide Enhances Chemosensitivity of Human Gastric Cancer Cells to Docetaxel Through Attenuating NF-κB Activation.

Authors:  Yuanming Pan; Shuye Lin; Rui Xing; Min Zhu; Bonan Lin; Jiantao Cui; Wenmei Li; Jing Gao; Lin Shen; Yuanyuan Zhao; Mingzhou Guo; Ji Ming Wang; Jiaqiang Huang; Youyong Lu
Journal:  Antioxid Redox Signal       Date:  2016-03-30       Impact factor: 8.401

9.  miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis.

Authors:  Tingting Huang; Wei Kang; Bin Zhang; Feng Wu; Yujuan Dong; Joanna H M Tong; Weiqin Yang; Yuhang Zhou; Li Zhang; Alfred S L Cheng; Jun Yu; Ka Fai To
Journal:  Mol Cancer       Date:  2016-01-22       Impact factor: 27.401

Review 10.  NF-κB Expression and Outcomes in Solid Tumors: A Systematic Review and Meta-Analysis.

Authors:  Dang Wu; Pin Wu; Lufeng Zhao; Lijian Huang; Zhigang Zhang; Shuai Zhao; Jian Huang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.